Cargando…
Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy()
Over the past decade, inhibition of the kinase activities of oncogenic proteins using small molecules and antibodies has been a mainstay of our anticancer drug development effort, resulting in several Food and Drug Administration–approved cancer therapies. The clinical effectiveness of kinase-target...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611070/ https://www.ncbi.nlm.nih.gov/pubmed/26476077 http://dx.doi.org/10.1016/j.neo.2015.08.008 |